Anika Gupta Vatsa, PhD
Principal
Google Ventures
GV principal investing in biotech companies developing new medicines.
Professional summary
David Schenkein is a general partner at GV and co-leads the firm's life science investment team. He invests across therapeutics, diagnostics, medical devices, care delivery, and payer innovation. Before GV, he was CEO and a board member at Agios Pharmaceuticals, held senior oncology roles at Genentech and Millennium Pharmaceuticals, and helped develop Velcade.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles